Evidence map›Paper›PMID 35003119›Full record

ArticleFrontiers in immunology2021

Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity.

Ludmila Perelygina, Raeesa Faisthalab, Emily Abernathy, Min-Hsin Chen, LiJuan Hao, Lionel Bercovitch, Diana K Bayer, Lenora M Noroski, Michael T Lam, Maria Pia Cicalese and 30 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Current infectious disease management challenges in inborn errors of immunity.Annals of clinical microbiology and antimicrobials · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rubella virus-associated cutaneous granulomatous disease in an immunocompetent woman.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  12. Review
  13. Article
  14. Review
  15. Cutaneous granulomas associated with rubella virus: A clinical review.Journal of the American Academy of Dermatology · 2024
    Review
  16. Surveillance for rubella virus in samples obtained from non-immunodeficient individuals.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Nature and nurture: understanding phenotypic variation in inborn errors of immunity.Frontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 20 institutions in 7 countries.

Ludmila PerelyginaCenters for Disease Control and Prevention, Division of Viral Diseases, Atlanta, GA, United States.
Raeesa FaisthalabCenters for Disease Control and Prevention, Division of Viral Diseases, Atlanta, GA, United States.
Emily AbernathyCenters for Disease Control and Prevention, Division of Viral Diseases, Atlanta, GA, United States.
Min-Hsin ChenCenters for Disease Control and Prevention, Division of Viral Diseases, Atlanta, GA, United States.
LiJuan HaoCenters for Disease Control and Prevention, Division of Viral Diseases, Atlanta, GA, United States.
Lionel BercovitchDepartment of Dermatology, Hasbro Children's Hospital and Warren Alpert Medical School of Brown University, Providence, RI, United States.
Diana K BayerDepartment of Pediatrics, University of Iowa Stead Family Children's Hospital, Iowa City, IA, United States.
Lenora M NoroskiDepartment of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States.
Michael T LamDepartment of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States.
Maria Pia CicalesePediatric Immunohematology and Bone Marrow Transplantation Unit and San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Istituto di Ricovero e Cura a Carattere Scientifico (National Institute for Research and Treatment) (IRCCS) San Raffaele Scientific Institute, Milan, Italy.
Waleed Al-HerzDepartment of Pediatrics, Kuwait University, Kuwait City, Kuwait.
Arti NandaPediatric Dermatology Unit, As'ad Al-Hamad Dermatology Center, Al-sabah Hospital, Kuwait City, Kuwait.
Joud HajjarDepartment of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States.
Koen Vanden DriesscheDepartment of Pediatrics, Queen Mathilde Mother and Child Centre, Antwerp University Hospital, Antwerp, Belgium.
Shari SchrovenDepartment of Pediatrics, Queen Mathilde Mother and Child Centre, Antwerp University Hospital, Antwerp, Belgium.
Julie LeysenDepartment of Dermatology, Queen Mathilde Mother and Child Centre, Antwerp University Hospital, Antwerp, Belgium.
Misha RosenbachDepartment of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States.
Philipp PetersDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Johannes RaedlerDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Michael H AlbertDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Roshini S AbrahamDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH, United States.
Hemalatha G RangarjanDepartment of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, United States.
David BuchbinderDepartment of Hematology, Children's Hospital of Orange County, Orange, CA, United States.
Lisa KobrynskiAllergy/Immunology Section, Emory University, Atlanta, GA, United States.
Anne Pham-HuyDepartment of Pediatrics, University of Ottawa and Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
Julie DhosscheDepartment of Dermatology, Oregon Health and Science University, Portland, OR, United States.
Charlotte Cunningham RundlesDivision of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Anna K MeyerDepartment of Pediatrics, National Jewish Health, Denver, CO, United States.
Amy TheosDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, United States.
T Prescott AtkinsonDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, United States.
Amy MusiekDivision of Dermatology, Washington University School of Medicine, St. Louis, MO, United States.
Mehdi AdeliDivision of Immunology and Allergy, Sidra Medicine and Hamad Medical Corporation, Doha, Qatar.
Ute DerichsCenter for Pediatric and Adolescent Medicine, University Medical Hospital Mainz, Mainz, Germany.
Christoph WalzInstitute of Pathology, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Renate KrügerDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Horst von BernuthDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Christoph KleinDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Joseph IcenogleCenters for Disease Control and Prevention, Division of Viral Diseases, Atlanta, GA, United States.
Fabian HauckDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Kathleen E SullivanDivision of Allergy Immunology, Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States.
Centers for Disease Control and Prevention · USLudwig-Maximilians-Universität München · DEAntwerp University Hospital · BEBaylor College of Medicine · USAl-Sabah Hospital · KWCharité - Universitätsmedizin Berlin · DENationwide Children's Hospital · USUniversity of Alabama at Birmingham · USChildren's Hospital of Eastern Ontario · CAEmory University · USHamad Medical Corporation · QAHasbro Children's Hospital · USIcahn School of Medicine at Mount Sinai · USIstituti di Ricovero e Cura a Carattere Scientifico · ITNational Jewish Health · USOregon Health & Science University · USPhiladelphia University · USUniversity Medical Center of the Johannes Gutenberg University Mainz · DEUniversity of California, Irvine · USUniversity of Iowa Stead Family Children’s Hospital · US

Funding

Unique ADP-ribosylating and vacuolating properties of Mycoplasma pneumoniae CARDS toxin trigger airway inflammation and disease progressionR01AI141877 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KANNAN, THIRUMALAI RENGASAMY · 2019 to 2023
$2.3M
Persistent rubella in immune deficient patientsR21AI130967 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI SULLIVAN, KATHLEEN E · 2018 to 2019
$473k
NIAID NIH HHS R01 AI141877NIAID NIH HHS R21 AI130967
6 · The paper itself

Abstract

Rubella virus (RuV) has recently been found in association with granulomatous inflammation of the skin and several internal organs in patients with inborn errors of immunity (IEI). The cellular tropism and molecular mechanisms of RuV persistence and pathogenesis in select immunocompromised hosts are not clear. We provide clinical, immunological, virological, and histological data on a cohort of 28 patients with a broad spectrum of IEI and RuV-associated granulomas in skin and nine extracutaneous tissues to further delineate this relationship. Combined immunodeficiency was the most frequent diagnosis (67.8%) among patients. Patients with previously undocumented conditions, i.e., humoral immunodeficiencies, a secondary immunodeficiency, and a defect of innate immunity were identified as being susceptible to RuV-associated granulomas. Hematopoietic cell transplantation was the most successful treatment in this case series resulting in granuloma resolution; steroids, and TNF-α and IL-1R inhibitors were moderately effective. In addition to M2 macrophages, neutrophils were identified by immunohistochemical analysis as a novel cell type infected with RuV. Four patterns of RuV-associated granulomatous inflammation were classified based on the structural organization of granulomas and identity and location of cell types harboring RuV antigen. Identification of conditions that increase susceptibility to RuV-associated granulomas combined with structural characterization of the granulomas may lead to a better understanding of the pathogenesis of RuV-associated granulomas and discover new targets for therapeutic interventions.

Indexed as

AgedAntigens, ViralCohort StudiesCytokinesDisease SusceptibilityFemaleGenetic Diseases, InbornGranulomaHematopoietic Stem Cell TransplantationHumansImmunohistochemistryImmunologic Deficiency SyndromesInflammationMacrophagesMaleMiddle AgedAntigens, ViralCytokinesReceptors, Interleukin-1Tumor Necrosis Factor-alphagranulomatous inflammationgranuloma treatmentsinborn errors of immunitymacrophagesneutrophilsprimary immunodeficiencyskin lesionvaccine-derived rubella viruses

Identifiers

PMID35003119
PMCPMC8728873
OpenAlexW4200320014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.